Published in EMBO J on May 01, 1984
The LDL receptor gene: a mosaic of exons shared with different proteins. Science (1985) 5.49
Primary structure of human fibronectin: differential splicing may generate at least 10 polypeptides from a single gene. EMBO J (1985) 5.47
Human epidermal growth factor precursor: cDNA sequence, expression in vitro and gene organization. Nucleic Acids Res (1986) 3.11
Sequence of the notch locus of Drosophila melanogaster: relationship of the encoded protein to mammalian clotting and growth factors. Mol Cell Biol (1986) 3.02
Molecular pathology of haemophilia B. EMBO J (1989) 2.74
Direct detection of point mutations by mismatch analysis: application to haemophilia B. Nucleic Acids Res (1989) 2.64
Deficient repair of the transcribed strand of active genes in Cockayne's syndrome cells. Nucleic Acids Res (1993) 2.45
Fine mapping of a replication origin of human DNA. Proc Natl Acad Sci U S A (1994) 2.44
Functionally important regions of the factor IX gene have a low rate of polymorphism and a high rate of mutation in the dinucleotide CpG. Am J Hum Genet (1989) 2.42
Vaccinia virus 19-kilodalton protein: relationship to several mammalian proteins, including two growth factors. Proc Natl Acad Sci U S A (1984) 2.34
The nucleotide sequence of the gene for human protein C. Proc Natl Acad Sci U S A (1985) 2.24
Molecular cloning and characterization of the cDNA coding for C4b-binding protein, a regulatory protein of the classical pathway of the human complement system. Biochem J (1985) 2.19
Speculations on the early course of evolution. Proc Natl Acad Sci U S A (1986) 2.15
Isolation of the human gene for bone gla protein utilizing mouse and rat cDNA clones. EMBO J (1986) 2.10
Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol (1986) 2.07
Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Res (1984) 2.00
Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J (1987) 2.00
Characterization of a cDNA coding for human factor VII. Proc Natl Acad Sci U S A (1986) 1.89
Expression of a human alpha-globin/fibronectin gene hybrid generates two mRNAs by alternative splicing. EMBO J (1984) 1.83
An alternative approach to somatic cell gene therapy. Proc Natl Acad Sci U S A (1988) 1.81
Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene. Am J Hum Genet (1990) 1.78
Nucleotide sequence of the gene coding for human factor VII, a vitamin K-dependent protein participating in blood coagulation. Proc Natl Acad Sci U S A (1987) 1.71
Primary structure of human complement component C2. Homology to two unrelated protein families. Biochem J (1986) 1.69
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res (1990) 1.64
Purification, chain separation and sequence of the MRC OX-8 antigen, a marker of rat cytotoxic T lymphocytes. EMBO J (1985) 1.63
Randomly picked cosmid clones overlap the pyrB and oriC gap in the physical map of the E. coli chromosome. Nucleic Acids Res (1988) 1.62
Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B. Am J Hum Genet (1999) 1.61
Identification of a third region of cell-specific alternative splicing in human fibronectin mRNA. Proc Natl Acad Sci U S A (1987) 1.55
Human mast cell tryptase: multiple cDNAs and genes reveal a multigene serine protease family. Proc Natl Acad Sci U S A (1990) 1.55
The role of beta-hydroxyaspartate and adjacent carboxylate residues in the first EGF domain of human factor IX. EMBO J (1988) 1.54
EGF homologous sequences encoded in the genome of Drosophila melanogaster, and their relation to neurogenic genes. EMBO J (1987) 1.52
MRC OX-2 antigen: a lymphoid/neuronal membrane glycoprotein with a structure like a single immunoglobulin light chain. EMBO J (1985) 1.40
A new strategy for the genetic counselling of diseases of marked mutational heterogeneity: haemophilia B as a model. J Med Genet (1992) 1.38
An intragenic deletion of the factor IX gene in a family with hemophilia B. J Clin Invest (1985) 1.32
Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs. Proc Natl Acad Sci U S A (1990) 1.28
The first EGF-like domain from human factor IX contains a high-affinity calcium binding site. EMBO J (1990) 1.26
Isolation and sequence of the cDNA for human protein S, a regulator of blood coagulation. Proc Natl Acad Sci U S A (1986) 1.22
Modified oligonucleotides as alternatives to the synthesis of mixed probes for the screening of cDNA libraries. Proc Natl Acad Sci U S A (1985) 1.18
Asynchronous replication of homologous loci on human active and inactive X chromosomes. Proc Natl Acad Sci U S A (1990) 1.17
Evolution and organization of the human protein C gene. Proc Natl Acad Sci U S A (1986) 1.14
Comparison of factor IX methylation on human active and inactive X chromosomes: implications for X inactivation and transcription of tissue-specific genes. EMBO J (1986) 1.13
Heterogeneity of the factor IX locus in nine hemophilia B inhibitor patients. J Clin Invest (1987) 1.12
Evidence for a prevalent dimorphism in the activation peptide of human coagulation factor IX. Proc Natl Acad Sci U S A (1985) 1.09
The human genes for hemophilia A and hemophilia B flank the X chromosome fragile site at Xq27.3. EMBO J (1985) 1.09
The structure and evolution of a 461 amino acid human protein C precursor and its messenger RNA, based upon the DNA sequence of cloned human liver cDNAs. Nucleic Acids Res (1985) 1.09
Haemophilia A and haemophilia B: molecular insights. Mol Pathol (2002) 1.09
Variants of human tissue-type plasminogen activator that lack specific structural domains of the heavy chain. EMBO J (1988) 1.08
Hemophilia B (factor IXSeattle 2) due to a single nucleotide deletion in the gene for factor IX. J Clin Invest (1987) 1.08
A factor IX mutation, verified by direct genomic sequencing, causes haemophilia B by a novel mechanism. EMBO J (1988) 1.06
Gene deletion in an Italian haemophilia B subject. J Med Genet (1985) 1.05
Structure of the rat ornithine carbamoyltransferase gene, a large, X chromosome-linked gene with an atypical promoter. Proc Natl Acad Sci U S A (1987) 1.05
Parental origin of factor IX gene mutations, and their distribution in the gene. Am J Hum Genet (1992) 1.01
Cloning and sequencing of full-length cDNA encoding the precursor of human complement component C1r. Biochem J (1986) 1.00
A rapid test for V(D)J recombinase activity. Nucleic Acids Res (1990) 0.99
Comparative sequence analysis of mammalian factor IX promoters. Nucleic Acids Res (1990) 0.97
Complete amino acid sequence of the A chain of human complement-classical-pathway enzyme C1r. Biochem J (1987) 0.96
Identification of a single nucleotide C-to-T transition and five different deletions in patients with severe hemophilia B. Am J Hum Genet (1989) 0.95
Population genetics of coagulant factor IX: frequencies of two DNA polymorphisms in five ethnic groups. Am J Hum Genet (1987) 0.95
Haemophilia A and haemophilia B: molecular insights. Mol Pathol (2002) 0.95
Molecular cloning and characterization of the complementary DNA and gene coding for the B-chain of subcomponent C1q of the human complement system. Biochem J (1985) 0.95
Nullisomic deletion of the mcf.2 transforming gene in two haemophilia B patients. EMBO J (1988) 0.95
Expression of active human blood clotting factor IX in transgenic mice: use of a cDNA with complete mRNA sequence. Nucleic Acids Res (1987) 0.93
Hemophilia B (Christmas disease) variants and carrier detection analyzed by DNA probes. J Clin Invest (1987) 0.89
Assessment of the F9 genotype-specific FIX inhibitor risks and characterisation of 10 novel severe F9 defects in the first molecular series of Argentinian patients with haemophilia B. Thromb Haemost (2012) 0.87
Monoclonal antibodies to coagulation factor IX define a high-frequency polymorphism by immunoassays. Am J Hum Genet (1985) 0.87
Polymorphism of normal factor IX detected by mouse monoclonal antibodies. Proc Natl Acad Sci U S A (1985) 0.86
Characterization of recombinant human factor IX expressed in transgenic mice and in derived trans-immortalized hepatic cell lines. EMBO J (1990) 0.85
Cloning and characterization of human liver cDNA encoding a protein S precursor. Proc Natl Acad Sci U S A (1987) 0.85
Application of an intragenic genomic probe to genetic counselling for haemophilia B in the west of Scotland. J Med Genet (1985) 0.84
An insertion within the factor IX gene: hemophilia BEl Salvador. Am J Hum Genet (1988) 0.83
Chromatin loop structure of the human X chromosome: relevance to X inactivation and CpG clusters. Mol Cell Biol (1989) 0.83
Vitamin K-dependent carboxylase: possible role of the substrate "propeptide" as an intracellular recognition site. Proc Natl Acad Sci U S A (1987) 0.82
Nonrandom X chromosome DNA methylation patterns in hemophiliac females. J Clin Invest (1989) 0.81
Fixing human factor IX (fIX): correction of a cryptic RNA splice enables the production of biologically active fIX in the mammary gland of transgenic mice. Proc Natl Acad Sci U S A (1995) 0.81
The propeptide region of clotting factor IX is a signal for a vitamin K dependent carboxylase: evidence from protein engineering of amino acid -4. Nucleic Acids Res (1987) 0.80
Partial factor IX protein in a pedigree with hemophilia B due to a partial gene deletion. J Clin Invest (1986) 0.80
The CDC Hemophilia B mutation project mutation list: a new online resource. Mol Genet Genomic Med (2013) 0.80
DNA sequence analysis: a procedure to find homologies among many sequences. Nucleic Acids Res (1986) 0.78
Regulation of Tacaribe Mammarenavirus Translation: Positive 5' and Negative 3' Elements, and Role of Key Cellular Factors. J Virol (2017) 0.76
Molecular Analysis of Factor VIII and Factor IX Genes in Hemophilia Patients: Identification of Novel Mutations and Molecular Dynamics Studies. J Clin Med Res (2017) 0.75
A genetic analysis of 23 Chinese patients with hemophilia B. Sci Rep (2016) 0.75
Sequencing end-labeled DNA with base-specific chemical cleavages. Methods Enzymol (1980) 287.68
Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. Biochemistry (1979) 180.95
Screening lambdagt recombinant clones by hybridization to single plaques in situ. Science (1977) 83.82
Colony hybridization: a method for the isolation of cloned DNAs that contain a specific gene. Proc Natl Acad Sci U S A (1975) 77.46
Sizing and mapping of early adenovirus mRNAs by gel electrophoresis of S1 endonuclease-digested hybrids. Cell (1977) 61.24
Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem (1981) 49.46
Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol (1980) 41.18
3' non-coding region sequences in eukaryotic messenger RNA. Nature (1976) 39.12
A new computer method for the storage and manipulation of DNA gel reading data. Nucleic Acids Res (1980) 36.42
Lambda replacement vectors carrying polylinker sequences. J Mol Biol (1983) 32.76
Mapping of RNA by a modification of the Berk-Sharp procedure: the 5' termini of 15 S beta-globin mRNA precursor and mature 10 s beta-globin mRNA have identical map coordinates. Nucleic Acids Res (1979) 31.23
The isolation and characterization of linked delta- and beta-globin genes from a cloned library of human DNA. Cell (1978) 22.88
Trans-complementable copy-number mutants of plasmid ColE1. Nature (1980) 17.11
The nucleotide sequence of the initiation and termination sites for ribosomal RNA transcription in X. laevis. Cell (1979) 11.64
Novel bacteriophage lambda cloning vector. Proc Natl Acad Sci U S A (1980) 8.97
Synthesis of double-stranded DNA complementary to lysozyme, ovomucoid, and ovalbumin mRNAs. Optimization for full length second strand synthesis by Escherichia coli DNA polymerase I. J Biol Chem (1978) 8.20
Filter replicas and permanent collections of recombinant DNA plasmids. Nucleic Acids Res (1979) 8.00
Base sequence studies of 300 nucleotide renatured repeated human DNA clones. J Mol Biol (1981) 7.94
Messenger RNA for the Ad2 DNA binding protein: DNA sequences encoding the first leader and heterogenity at the mRNA 5' end. Cell (1979) 5.28
Functional relationships between transcriptional control signals of the thymidine kinase gene of herpes simplex virus. Cell (1982) 5.03
Structure and in vitro transcription of human globin genes. Science (1980) 4.65
Structure and genomic organization of the mouse dihydrofolate reductase gene. Cell (1980) 4.25
The sequence of the nucleoprotein gene of human influenza A virus, strain A/NT/60/68. Nucleic Acids Res (1982) 3.99
Isolation of a genomic clone partially encoding human hypoxanthine phosphoribosyltransferase. Proc Natl Acad Sci U S A (1982) 3.49
Isolation and characterization of a cDNA coding for human factor IX. Proc Natl Acad Sci U S A (1982) 3.14
AUG is the only recognisable signal sequence in the 5' non-coding regions of eukaryotic mRNA. Nature (1978) 2.76
Complete nucleotide sequence of the 5' noncoding region of human alpha-and beta-globin mRNA. Cell (1977) 2.62
Gene deletions in patients with haemophilia B and anti-factor IX antibodies. Nature (1983) 2.59
Isolation of a human anti-haemophilic factor IX cDNA clone using a unique 52-base synthetic oligonucleotide probe deduced from the amino acid sequence of bovine factor IX. Nucleic Acids Res (1983) 2.56
Molecular cloning of the gene for human anti-haemophilic factor IX. Nature (1982) 2.50
Characterization of the complementary deoxyribonucleic acid and gene coding for human prothrombin. Biochemistry (1983) 2.49
Structure of mouse kallikrein gene family suggests a role in specific processing of biologically active peptides. Nature (1983) 2.25
Regional localization on the human X chromosome and polymorphism of the coagulation factor IX gene (hemophilia B locus). Proc Natl Acad Sci U S A (1984) 2.23
Characterisation and use of an intragenic polymorphic marker for detection of carriers of haemophilia B (factor IX deficiency). Lancet (1984) 2.08
Comparison of amino acid sequence of bovine coagulation Factor IX (Christmas Factor) with that of other vitamin K-dependent plasma proteins. Proc Natl Acad Sci U S A (1979) 1.77
Carrier detection by direct gene analysis in a family with haemophilia B (factor IX deficiency). Lancet (1984) 1.74
Intron-exon splice junctions map at protein surfaces. Nature (1982) 1.65
beta-Hydroxyaspartic acid in vitamin K-dependent protein C. Proc Natl Acad Sci U S A (1983) 1.26
Molecular cloning and characterization of the gene coding for human complement protein factor B. Proc Natl Acad Sci U S A (1983) 1.24
Assignment of the haemophilia B (factor IX) locus to the q26-qter region of the X chromosome. Ann Hum Genet (1984) 1.10
3' non-coding region sequences in eukaryotic messenger RNA. Nature (1976) 39.12
A two-dimensional fractionation procedure for radioactive nucleotides. J Mol Biol (1965) 20.83
Chromatography of 32P-labelled oligonucleotides on thin layers of DEAE-cellulose. Eur J Biochem (1969) 15.21
The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype). Cell (1982) 12.44
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
A possible precursor of immunoglobulin light chains. Nat New Biol (1972) 11.03
New rapid gel sequencing method for RNA. Nature (1977) 9.56
Sequence of chicken ovalbumin mRNA. Nature (1978) 6.73
The sequence of 5 s ribosomal ribonucleic acid. J Mol Biol (1968) 6.47
The nucleotide sequence of oocyte 5S DNA in Xenopus laevis. II. The GC-rich region. Cell (1978) 5.87
The Talin head domain binds to integrin beta subunit cytoplasmic tails and regulates integrin activation. J Biol Chem (1999) 4.92
Nucleotide sequence of the haemagglutinin gene of a human influenza virus H1 subtype. Nature (1981) 4.86
Rapid gel sequencing of RNA by primed synthesis with reverse transcriptase. J Mol Biol (1977) 4.72
Survivin and the inner centromere protein INCENP show similar cell-cycle localization and gene knockout phenotype. Curr Biol (2000) 4.27
Sequence at the 3' end of globin mRNA shows homology with immunoglobulin light chain mRNA. Nature (1974) 4.24
The sequence of the nucleoprotein gene of human influenza A virus, strain A/NT/60/68. Nucleic Acids Res (1982) 3.99
Cytotoxic T cell recognition of the influenza nucleoprotein and hemagglutinin expressed in transfected mouse L cells. Cell (1984) 3.97
Adherence of bacteria to heart valves in vitro. J Clin Invest (1975) 3.74
The influenza virus panhandle is involved in the initiation of transcription. J Virol (1994) 3.56
Structure of the neuraminidase gene in human influenza virus A/PR/8/34. Nature (1981) 3.56
Early disruption of centromeric chromatin organization in centromere protein A (Cenpa) null mice. Proc Natl Acad Sci U S A (2000) 3.53
A functional neo-centromere formed through activation of a latent human centromere and consisting of non-alpha-satellite DNA. Nat Genet (1997) 3.36
The antigenicity and evolution of influenza H1 haemagglutinin, from 1950-1957 and 1977-1983: two pathways from one gene. Virology (1986) 3.34
Nucleotide sequence homology at 12 intron--exon junctions in the chick ovalbumin gene. Nature (1978) 3.30
Nucleotide sequences from the low molecular weight ribosomal RNA of Escherichia coli. J Mol Biol (1967) 3.06
Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med (1988) 2.85
A new method for reconstituting influenza polymerase and RNA in vitro: a study of the promoter elements for cRNA and vRNA synthesis in vitro and viral rescue in vivo. Virology (1992) 2.85
AUG is the only recognisable signal sequence in the 5' non-coding regions of eukaryotic mRNA. Nature (1978) 2.76
Molecular pathology of haemophilia B. EMBO J (1989) 2.74
Complete nucleotide sequence of the chicken chromosomal ovalbumin gene and its biological significance. Biochemistry (1981) 2.67
Direct detection of point mutations by mismatch analysis: application to haemophilia B. Nucleic Acids Res (1989) 2.64
The absence of myristic acid decreases membrane binding of p60src but does not affect tyrosine protein kinase activity. J Virol (1986) 2.59
Gene deletions in patients with haemophilia B and anti-factor IX antibodies. Nature (1983) 2.59
Bub3 gene disruption in mice reveals essential mitotic spindle checkpoint function during early embryogenesis. Genes Dev (2000) 2.53
Characterization of the RNA-fork model of virion RNA in the initiation of transcription in influenza A virus. J Virol (1995) 2.52
Molecular cloning of the gene for human anti-haemophilic factor IX. Nature (1982) 2.50
Cytotoxic T lymphocytes recognize influenza haemagglutinin that lacks a signal sequence. Nature (1987) 2.44
Antigenicity and evolution amongst recent influenza viruses of H1N1 subtype. Nucleic Acids Res (1983) 2.41
The use of synthetic oligodeoxynucleotide primers in cloning and sequencing segment of 8 influenza virus (A/PR/8/34). Nucleic Acids Res (1981) 2.40
Nucleotide sequence of 5S-ribosomal RNA from Escherichia coli. Nature (1967) 2.30
The 3' terminal sequence of chicken ovalbumin messenger RNA and its comparison with other messenger RNA molecules. J Mol Biol (1976) 2.29
An ancient, highly conserved family of cysteine-rich protein domains revealed by cloning type I and type II murine macrophage scavenger receptors. Proc Natl Acad Sci U S A (1990) 2.24
Sequence analysis of immunoglobulin light chain messenger RNA. Nature (1974) 2.22
Photochemical cross-linking of influenza A polymerase to its virion RNA promoter defines a polymerase binding site at residues 9 to 12 of the promoter. J Gen Virol (1993) 2.17
Incorporation of 3H from delta-(L-alpha-amino (4,5-3H)adipyl)-L-cysteinyl-D-(4,4-3H)valine into isopenicillin N. Biochem J (1979) 2.14
A new method for the size estimation of the RNA genome segments of influenza virus. Nucleic Acids Res (1979) 2.12
Characterisation and use of an intragenic polymorphic marker for detection of carriers of haemophilia B (factor IX deficiency). Lancet (1984) 2.08
Sequence of 6S RNA of E. coli. Nat New Biol (1971) 2.06
Orthomyxovirus replication, transcription, and polyadenylation. Curr Top Microbiol Immunol (2004) 2.04
A functional marker centromere with no detectable alpha-satellite, satellite III, or CENP-B protein: activation of a latent centromere? Am J Hum Genet (1993) 2.03
Direct evidence that the poly(A) tail of influenza A virus mRNA is synthesized by reiterative copying of a U track in the virion RNA template. J Virol (1999) 2.01
Carrier detection in haemophilia B using two further intragenic restriction fragment length polymorphisms. Nucleic Acids Res (1984) 2.00
The influenza virus haemagglutinin gene: cloning and characterisation of a double-stranded DNA copy. Nucleic Acids Res (1979) 1.98
The 10q25 neocentromere and its inactive progenitor have identical primary nucleotide sequence: further evidence for epigenetic modification. Genome Res (2000) 1.96
Talin contains three actin-binding sites each of which is adjacent to a vinculin-binding site. J Cell Sci (1996) 1.95
The identification of the chromosomes of the D group (13-15) Denver: an autoradiographic and measurement study. Cytogenetics (1966) 1.95
The complete sequence of RNA segment 2 of influenza A/NT/60/68 P1 protein. Nucleic Acids Res (1982) 1.92
Hunter syndrome: isolation of an iduronate-2-sulfatase cDNA clone and analysis of patient DNA. Proc Natl Acad Sci U S A (1990) 1.91
Determination of blood lead levels. S Afr Med J (1991) 1.90
Targeting and germ-line transmission of a null mutation at the metallothionein I and II loci in mouse. Proc Natl Acad Sci U S A (1993) 1.88
Targeted disruption of mouse centromere protein C gene leads to mitotic disarray and early embryo death. Proc Natl Acad Sci U S A (1998) 1.86
Synthesis of delta-(alpha-aminoadipyl)cysteinylvaline and its role in penicillin biosynthesis. Biochem J (1976) 1.86
The structure of a Ca(2+)-binding epidermal growth factor-like domain: its role in protein-protein interactions. Cell (1995) 1.84
Defective propeptide processing of blood clotting factor IX caused by mutation of arginine to glutamine at position -4. Cell (1986) 1.82
An improved direct RNA sequence method; its application to Vicia faba 5.8S ribosomal RNA. Nucleic Acids Res (1980) 1.80
A novel chromatin immunoprecipitation and array (CIA) analysis identifies a 460-kb CENP-A-binding neocentromere DNA. Genome Res (2001) 1.75
Detection of polymorphisms at cytosine phosphoguanadine dinucleotides and diagnosis of haemophilia B carriers. Lancet (1989) 1.74
Completion of the detailed restriction map of the E. coli genome by the isolation of overlapping cosmid clones. Nucleic Acids Res (1989) 1.71
Sequence of three introns in the chick ovalbumin gene. Nature (1979) 1.69
Polyadenylation of influenza virus mRNA transcribed in vitro from model virion RNA templates: requirement for 5' conserved sequences. J Virol (1998) 1.68
Key residues involved in calcium-binding motifs in EGF-like domains. Nature (1991) 1.68
Centromere protein B null mice are mitotically and meiotically normal but have lower body and testis weights. J Cell Biol (1998) 1.68
Disruption of a C/EBP binding site in the factor IX promoter is associated with haemophilia B. Nature (1990) 1.68
A pseudogene structure in 5S DNA of Xenopus laevis. Cell (1977) 1.67
Molecular characterization of de novo secondary trisomy 13. Am J Hum Genet (1994) 1.66
A 330 kb CENP-A binding domain and altered replication timing at a human neocentromere. EMBO J (2001) 1.65
DNA variation in a 5-Mb region of the X chromosome and estimates of sex-specific/type-specific mutation rates. Am J Hum Genet (1999) 1.64
The incidence and distribution of CpG----TpG transitions in the coagulation factor IX gene. A fresh look at CpG mutational hotspots. Nucleic Acids Res (1990) 1.64
Human centromeres and neocentromeres show identical distribution patterns of >20 functionally important kinetochore-associated proteins. Hum Mol Genet (2000) 1.63
Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol (1998) 1.63
A note on transfer of stimulus control in the delayed-cue procedure: facilitation by an overt differential response. J Appl Behav Anal (1994) 1.63
Randomly picked cosmid clones overlap the pyrB and oriC gap in the physical map of the E. coli chromosome. Nucleic Acids Res (1988) 1.62
Mutation rates in humans. I. Overall and sex-specific rates obtained from a population study of hemophilia B. Am J Hum Genet (1999) 1.61
Genetics of the mammalian phenylalanine hydroxylase system. Studies of human liver phenylalanine hydroxylase subunit structure and of mutations in phenylketonuria. Biochem J (1979) 1.61